The Union Budget 2026-27 announced Biopharma SHAKTI (Strategy for Healthcare Advancement through Knowledge, Technology, and Innovation) with ₹10,000 crore outlay over five years to position India as a global biomanufacturing hub. The scheme will support domestic production of biologics and biosimilars targeting cancer, diabetes, and autoimmune disorders, establish 3 new NIPERs, upgrade 7 existing ones, and create a network of over 1,000 accredited clinical trial sites.

Separately, ₹20,000 crore was allocated for Carbon Capture, Utilization and Storage (CCUS) across five industrial sectors — power, steel, cement, refineries, and chemicals — aligned with the national CCUS roadmap released in December 2025 and India's Net Zero 2070 strategy. Nuclear energy received customs duty exemptions extended until 2035, with the door opened for private participation in small modular reactors.